CD38 and cancer: These nanotubes are dependent on CD38 for their formation and both genetic knock-down of CD38 and treatment with CD38 antibody interfere with the formation of these nanotubes and with mitochondrial transfer, and thereby, inhibit proliferation and reduce survival of the cancer cells.